Lingual dystonia as the first manifestation of multiple sclerosis (PP-22)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Farid Shamlou


MS and exercise (PP-23)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Maryam Abolhasani; Farzin Halabchi


Multidisciplinary rehabilitative management (PP-24)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Razieh Pirzad


Multiple sclerosis relapse after COVID-19 vaccination: A case report-based systematic review (PP-25)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Fardin Nabizadeh; Elham Ramezannezhad; Kimia Kazemzadeh; Elham Khalili; Elham Moases Ghaffary; Omid Mirmosayyeb


Neurosarcoidosis in an adult man with a family history of MS: A Case report (PP-26)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Elham Sadat Azimi


Patterns of Attention Deficit in Relapsing and Progressive Phenotypes of Multiple Sclerosis (PP-27)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Farinaz Tabibian; Kiarash Azimzadeh; Vahid Shaygannejad; Fereshteh Ashtari; Iman Adibi; Mehdi Sanayei


Personality traits of patients with multiple sclerosis and their correlation with anxiety and depression levels: A cross-sectional case-control study (PP-28)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Amir Ali Gharemani


Comparison of COVID-19 infection, Acute Relapse, and Adverse Effects Following COVID-19 Vaccination Between Patients with Multiple Sclerosis and Other Neurological Disorders (PP-29)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Mohammad Yazdan Panah; Saeed Vaheb; Yousef Mokary; Elham Moases Ghaffary; Alireza Afshari-Safavi; Aysa Shaygannejad; Narges Ebrahimi; Vahid Shaygannejad; Omid Mirmosayyeb


Pharmacogenomics of Multiple Sclerosis: Sieving treatment biomarkers from blood gene-expression profiles (PP-30)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Maryam Mohaghegh; Mohammad Hossein Sanati; Mitra Ataei; Mehdi Sadeghi; Shokoufeh Alayi